Celgene fronts Silverback in series A round

Sep 24, 2018 • Robert Lavine

Silverback Therapeutics, which is developing drugs that will only act at the site of disease, has closed a $47.5m round backed by Celgene.

Silverback Therapeutics, a US-based startup working on locally active medicines, has completed a $47.5m series A round featuring pharmaceutical firm Celgene.

Healthcare investment firm OrbiMed led the round, which included Alexandria Venture Investments, the venture capital branch of life sciences real estate investment trust Alexandria Real Estate Equities.

Silverback is developing therapies through its ImmunoTac platform for conditions such as cancer and fibrosis. The drugs will act at the site of a disease, meaning tissue elsewhere can be protected from…

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

FUNDING ROUND DATA

Which corporates are backing which startups? Search our corporate deal database.

CVC DIRECTORY

Find details about global CVC units in the CVC Directory

SPECIAL REPORT

Finding a new path: How venture units guide corporations through transformational change

Events

GCV Institute: CVC Investment Programs

Jan 28 -
Jan 29, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

May 1 -
May 6, 2025
Online

Find out more All events

Events

GCV Symposium 2025

Jun 17 -
Jun 19, 2025
London (UK)

Find out more All events

About us

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.